サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：血管内ステントの世界市場：2023-2030年
市場調査レポート
商品コード
1380412

血管内ステントの世界市場：2023-2030年

Global Intravascular Stents Market 2023-2030
出版日: | 発行: Orion Market Research | ページ情報: 英文 175 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
血管内ステントの世界市場：2023-2030年
出版日: 2023年09月27日
発行: Orion Market Research
ページ情報: 英文 175 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の血管内ステント市場は予測期間（2023-2030年）にCAGR 9.4％で成長すると予測されます。末梢血管疾患（PVDs）と冠動脈疾患（CADs）の有病率の増加を含む極めて重要な要因。世界保健機関（WHO）によると、心血管疾患（CVD）は世界の死因の第1位であり、毎年1,790万人の命が奪われていると推定されています。さらに、血管内ステントに関する合意や買収の増加は、これらのデバイスの受け入れと使用の増加を促進することにより、市場の成長を促進すると予測されています。2021年12月、医療技術のパイオニアであるロイヤル・フィリップスは、低侵襲性末梢血管デバイスを開発する米国の医療技術企業Vesper Medical Inc.を買収する契約を締結しました。ヴェスパー・メディカルは、深部静脈疾患治療用の先進的な静脈ステント・ポートフォリオにより、フィリップスの診断・治療機器のポートフォリオをさらに拡大しました。

セグメント別展望

冠動脈ステントのサブセグメントが世界の血管内ステント市場でかなりのシェアを占めると予想されます。

製品の中では、冠動脈ステントのサブセグメントが世界の血管内ステント市場でかなりのシェアを占めると予想されています。このセグメントの成長は、プラークが動脈に蓄積して発生するCADの有病率の増加により、ステントを含む経皮的冠動脈インターベンション治療の需要が高まっていることに起因しています。National Library of Medicineの研究によると、Raoらによって行われたシステマティックレビューでは、都市部におけるCADの有病率は2.5～12.6％、農村部では1.4～4.6％でした。さらに、FDA（食品医薬品局）による製品の承認件数の増加も、冠動脈ステントの採用拡大に寄与しています。例えば、米国FDAは2022年5月、CAD患者の治療用としてMedtronic社の薬剤溶出ステント（DES）Onyx Frontierを承認しました。この新しいDES製品は、MedtronicのResolute Onyxと同じプラットフォームを活用し、ドラッグデリバリーを改善し、急性期のパフォーマンスを向上させるように設計されています。

地域別展望

世界の血管内ステント市場は、北米（米国、カナダ）、欧州（英国、イタリア、スペイン、ドイツ、フランス、その他欧州地域）、アジア太平洋地域（インド、中国、日本、韓国、その他アジア地域）、世界のその他の地域（中東とアフリカ、中南米）を含む地域別にさらに細分化されています。なかでもアジア太平洋地域は、CVDの有病率の増加やライフスタイルの変化に起因して、世界市場で突出したシェアを占めると予想されます。

北米地域は血管内ステントの世界市場で大きなCAGRで成長する見込み

すべての地域の中で、北米地域は予測期間中にかなりのCAGRで成長すると予測されています。北米市場を牽引する主な要因は、北米全域で心血管系疾患が増加していることであり、今後数年間はステント市場の成長にプラスの影響を与えると推定されます。慢性疾患患者の増加は、経皮的冠動脈インターベンションと末梢血管処置の需要を促進すると予想されます。米国心臓協会（AHA）によると、CVDは依然として米国の主要な死因であり、2020年の死亡者数は928,741人です。2020年の米国におけるCVDに起因する死亡原因の第1位は冠動脈性心疾患（CHD）で41.2％、第2位は脳卒中（17.3％）、第3位はその他のCVD（16.8％）、第4位は高血圧（12.9％）、第5位は心不全（9.2％）、第6位は動脈の疾患（2.6％）でした。

目次

第1章 レポート概要

  • 業界の現状分析と成長ポテンシャルの展望
  • 調査方法とツール
  • 市場内訳
    • セグメント別
    • 地域別

第2章 市場概要と洞察

  • 調査範囲
  • アナリストの洞察と現在の市場動向
    • 主な調査結果
    • 推奨事項
    • 結論

第3章 競合情勢

  • 主要企業分析
  • B. Braun SE
    • 概要
    • 財務分析
    • SWOT分析
    • 最近の動向
  • Medtronic plc
    • 会社概要
    • 財務分析
    • SWOT分析
    • 最近の動向
  • Terumo Corp.
    • 概要
    • 財務分析
    • SWOT分析
    • 最近の動向
  • Stryker Corp.
    • 概要
    • 財務分析
    • SWOT分析
    • 最近の動向
  • 主要戦略分析

第4章 市場セグメンテーション

  • 血管内ステントの世界市場：製品別
    • 冠動脈ステント
    • 神経血管ステント
    • 末梢ステント
    • 腎動脈ステント
    • 大動脈ステント
  • 血管内ステントの世界市場：デリバリーモード別
    • 自己拡張型ステント
    • バルーン拡張型ステント
  • 血管内ステントの世界市場：エンドユーザー別
    • 病院および心臓センター
    • 外来手術センター

第5章 地域別分析

  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • イタリア
    • スペイン
    • フランス
    • その他欧州
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋地域
  • 世界のその他の地域

第6章 企業プロファイル

  • Abbott Laboratories
  • BIOTRONIK SE & Co KG
  • Boston Scientific Corp.
  • Cook Group Inc.
  • Elixir Medical Corp.
  • Hellman & Friedman LLC
  • Integer Holdings Corp.
  • iVascular, SLU
  • LifeTech Scientific Corp.
  • Meril Life Sciences Pvt. Ltd.
  • MicroPort Scientific Corp.
  • Stentys S.A.
  • Vascular Concepts Ltd.
  • Veryan Holdings Ltd.
  • VESALIO, LLC
図表

LIST OF TABLES

  • 1. GLOBAL INTRAVASCULAR STENTS MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2022-2030 ($ MILLION)
  • 2. GLOBAL CORONARY STENTS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 3. GLOBAL NEUROVASCULAR STENTS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 4. GLOBAL PERIPHERAL STENTS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 5. GLOBAL RENAL ARTERY STENTS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 6. GLOBAL AORTIC STENTS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 7. GLOBAL INTRAVASCULAR STENTS MARKET RESEARCH AND ANALYSIS BY MODE OF DELIVERY, 2022-2030 ($ MILLION)
  • 8. GLOBAL SELF-EXPANDING INTRAVASCULAR STENTS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 9. GLOBAL BALLOON-EXPANDABLE INTRAVASCULAR STENTS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 10. GLOBAL INTRAVASCULAR STENTS MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
  • 11. GLOBAL INTRAVASCULAR STENTS FOR HOSPITALS AND CARDIAC CENTERS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 12. GLOBAL INTRAVASCULAR STENTS FOR AMBULATORY SURGICAL CENTERS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 13. GLOBAL INTRAVASCULAR STENTS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 14. NORTH AMERICAN INTRAVASCULAR STENTS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 15. NORTH AMERICAN INTRAVASCULAR STENTS MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2022-2030 ($ MILLION)
  • 16. NORTH AMERICAN INTRAVASCULAR STENTS MARKET RESEARCH AND ANALYSIS BY MODE OF DELIVERY, 2022-2030 ($ MILLION)
  • 17. NORTH AMERICAN INTRAVASCULAR STENTS MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
  • 18. EUROPEAN INTRAVASCULAR STENTS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 19. EUROPEAN INTRAVASCULAR STENTS MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2022-2030 ($ MILLION)
  • 20. EUROPEAN INTRAVASCULAR STENTS MARKET RESEARCH AND ANALYSIS BY MODE OF DELIVERY, 2022-2030 ($ MILLION)
  • 21. EUROPEAN INTRAVASCULAR STENTS MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
  • 22. ASIA-PACIFIC INTRAVASCULAR STENTS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 23. ASIA-PACIFIC INTRAVASCULAR STENTS MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2022-2030 ($ MILLION)
  • 24. ASIA-PACIFIC INTRAVASCULAR STENTS MARKET RESEARCH AND ANALYSIS BY MODE OF DELIVERY, 2022-2030 ($ MILLION)
  • 25. ASIA-PACIFIC INTRAVASCULAR STENTS MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
  • 26. REST OF THE WORLD INTRAVASCULAR STENTS MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2022-2030 ($ MILLION)
  • 27. REST OF THE WORLD INTRAVASCULAR STENTS MARKET RESEARCH AND ANALYSIS BY MODE OF DELIVERY, 2022-2030 ($ MILLION)
  • 28. REST OF THE WORLD INTRAVASCULAR STENTS MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL INTRAVASCULAR STENTS MARKET SHARE BY PRODUCT, 2022 VS 2030 (%)
  • 2. GLOBAL CORONARY STENTS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 3. GLOBAL NEUROVASCULAR STENTS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 4. GLOBAL PERIPHERAL STENTS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 5. GLOBAL RENAL ARTERY STENTS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 6. GLOBAL AORTIC STENTS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 7. GLOBAL INTRAVASCULAR STENTS MARKET SHARE BY MODE OF DELIVERY, 2022 VS 2030 (%)
  • 8. GLOBAL SELF-EXPANDING INTRAVASCULAR STENTS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 9. GLOBAL BALLOON-EXPANDABLE INTRAVASCULAR STENTS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 10. GLOBAL INTRAVASCULAR STENTS MARKET SHARE BY END-USER, 2022 VS 2030 (%)
  • 11. GLOBAL INTRAVASCULAR STENTS FOR HOSPITALS AND CARDIAC CENTERS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 12. GLOBAL INTRAVASCULAR STENTS FOR AMBULATORY SURGICAL CENTERS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 13. GLOBAL INTRAVASCULAR STENTS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 14. US INTRAVASCULAR STENTS MARKET SIZE, 2022-2030 ($ MILLION)
  • 15. CANADA INTRAVASCULAR STENTS MARKET SIZE, 2022-2030 ($ MILLION)
  • 16. UK INTRAVASCULAR STENTS MARKET SIZE, 2022-2030 ($ MILLION)
  • 17. FRANCE INTRAVASCULAR STENTS MARKET SIZE, 2022-2030 ($ MILLION)
  • 18. GERMANY INTRAVASCULAR STENTS MARKET SIZE, 2022-2030 ($ MILLION)
  • 19. ITALY INTRAVASCULAR STENTS MARKET SIZE, 2022-2030 ($ MILLION)
  • 20. SPAIN INTRAVASCULAR STENTS MARKET SIZE, 2022-2030 ($ MILLION)
  • 21. REST OF EUROPE INTRAVASCULAR STENTS MARKET SIZE, 2022-2030 ($ MILLION)
  • 22. INDIA INTRAVASCULAR STENTS MARKET SIZE, 2022-2030 ($ MILLION)
  • 23. CHINA INTRAVASCULAR STENTS MARKET SIZE, 2022-2030 ($ MILLION)
  • 24. JAPAN INTRAVASCULAR STENTS MARKET SIZE, 2022-2030 ($ MILLION)
  • 25. SOUTH KOREA INTRAVASCULAR STENTS MARKET SIZE, 2022-2030 ($ MILLION)
  • 26. REST OF ASIA-PACIFIC INTRAVASCULAR STENTS MARKET SIZE, 2022-2030 ($ MILLION)
  • 27. REST OF THE WORLD INTRAVASCULAR STENTS MARKET SIZE, 2022-2030 ($ MILLION)
目次
Product Code: OMR2027821

Title: Global Intravascular Stents Market Size, Share & Trends Analysis Report by Product (Coronary Stents, Neurovascular Stents, Peripheral Stents, Renal Artery Stents, and Aortic Stents), by Mode of Delivery (Self-Expanding Stents and Balloon-Expandable Stents), by End-User (Hospitals and Cardiac Centers and Ambulatory Surgical Centers),Forecast Period (2023-2030).

The global intravascular stents market is anticipated to grow at a CAGR of 9.4% during the Forecast Period (2023-2030). Pivotal factors including the increasing prevalence of peripheral vascular diseases (PVDs) and coronary artery diseases (CAD). According to the World Health Organization (WHO), cardiovascular diseases (CVDs) are the leading cause of death globally, taking an estimated 17.9 million lives each year. Further, the increasing agreement and acquisition for intravascular stents is projected to drive market growth by promoting increased acceptance and usage of these devices. In December 2021, Royal Philips, a pioneer in health technology signed an agreement to acquire Vesper Medical Inc., a US-based medical technology company that developed minimally invasive peripheral vascular devices. Vesper Medical further expanded Philips' portfolio of diagnostic and therapeutic devices with an advanced venous stent portfolio for the treatment of deep venous disease.

Segmental Outlook

The global intravascular stents market is segmented on the product, mode of delivery and end-user. Based on the type, the market is sub-segmented into coronary stents, neurovascular stents, peripheral stents, renal artery stents and aortic stents. Based on the mode of delivery, the market is sub-segmented into self-expanding stents and balloon-expandable stents. Further, based on end-user, the market is sub-segmented into hospitals and cardiac centers and ambulatory surgical centers. Among the end-user, the hospitals and cardiac centers sub-segment is anticipated to hold a considerable share of the market, owing to the well-equipped settings, easy availability, high trust, and reliability.

The Coronary Stents Sub-Segment is Anticipated to Hold a Considerable Share of the Global Intravascular Stents Market

Among the product, the coronary stents sub-segment is expected to hold a considerable share of the global intravascular stents market. The segmental growth is attributed to the increasing prevalence of CADs, which occur when plaque accumulates in the arteries, has led to a growing demand for percutaneous coronary intervention treatments involving stents. According to the study of National Library of Medicine, the systematic review done by Rao et al. demonstrated that prevalence of CAD in urban areas was 2.5-12.6% and in rural areas, 1.4-4.6%. Additionally, the rising number of Food and Drug Administration (FDA) approvals of the products are also contributing to the increasing adoption for coronary stents. For instance, in May 2022, the US FDA approved drug-eluting stent (DES) Onyx Frontier, from Medtronic, for the treatment of patients with CAD. The new DES product leverages the same platform as Medtronic's Resolute Onyx, designed to improve the delivery of drugs and improve acute performance.

Regional Outlook

The global intravascular stents market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America). Among these, Asia-Pacific is anticipated to hold a prominent share of the market across the globe, owing to the increasing prevalence of CVDs, and the and changes in lifestyles.

The North America Region is Expected to Grow at a Significant CAGR in the Global Intravascular Stents Market

Among all regions, the North America regions is anticipated to grow at a considerable CAGR over the forecast period. The major factors driving the North America market is the increasing number of cardiovascular disorders across the North America is estimated to positively impact the stents market growth in upcoming years. Increasing patient pool with chronic diseases is expected to drive the demand for percutaneous coronary intervention and peripheral vascular procedures. According to the American Heart Association (AHA), CVDs remains as the leading cause of death in the US, accounted for 928,741 mortalities in the year 2020. In 2020 in the US, coronary heart disease (CHD) was the leading cause (41.2%) of deaths attributable to CVD in the US, followed by stroke (17.3%), other CVD (16.8%), high blood pressure (12.9%), heart failure (9.2%), diseases of the arteries (2.6%).

Market Players Outlook

The major companies serving the global intravascular stents market include: Abbott Laboratories, B. Braun SE, Boston Scientific Corp., Medtronic plc, Terumo Corp., and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in November 2022, Boston Scientific Corp., acquired the Devoro Medical, Inc., developer of the WOLF Thrombectomy® Platform, to add mechanical thrombectomy platform to peripheral interventions portfolio. The innovative non-console and lytic-free WOLF technology targets and rapidly captures blood clots using finger-like prongs that retrieve and remove thrombi in the arterial and venous systems.

The Report Covers:

  • Market value data analysis of 2022 and forecast to 2030.
  • Annualized market revenues ($ million) for each market segment.
  • Country-wise analysis of major geographical regions.
  • Key companies operating in the global intravascular stents market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
  • Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
  • Analysis of market-entry and market expansion strategies.
  • Competitive strategies by identifying 'who-stands-where' in the market.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
  • 3.2. B. Braun SE
    • 3.2.1. Overview
    • 3.2.2. Financial Analysis
    • 3.2.3. SWOT Analysis
    • 3.2.4. Recent Developments
  • 3.3. Medtronic plc
    • 3.3.1. Overview
    • 3.3.2. Financial Analysis
    • 3.3.3. SWOT Analysis
    • 3.3.4. Recent Developments
  • 3.4. Terumo Corp.
    • 3.4.1. Overview
    • 3.4.2. Financial Analysis
    • 3.4.3. SWOT Analysis
    • 3.4.4. Recent Developments
  • 3.5. Stryker Corp.
    • 3.5.1. Overview
    • 3.5.2. Financial Analysis
    • 3.5.3. SWOT Analysis
    • 3.5.4. Recent Developments
  • 3.6. Key Strategy Analysis

4. Market Segmentation

  • 4.1. Global Intravascular Stents Market by Product
    • 4.1.1. Coronary Stents
    • 4.1.2. Neurovascular Stents
    • 4.1.3. Peripheral Stents
    • 4.1.4. Renal Artery Stents
    • 4.1.5. Aortic Stents
  • 4.2. Global Intravascular Stents Market by Mode of Delivery
    • 4.2.1. Self-Expanding Stents
    • 4.2.2. Balloon-Expandable Stents
  • 4.3. Global Intravascular Stents Market by End-User
    • 4.3.1. Hospitals and Cardiac Centers
    • 4.3.2. Ambulatory Surgical Centers

5. Regional Analysis

  • 5.1. North America
    • 5.1.1. United States
    • 5.1.2. Canada
  • 5.2. Europe
    • 5.2.1. UK
    • 5.2.2. Germany
    • 5.2.3. Italy
    • 5.2.4. Spain
    • 5.2.5. France
    • 5.2.6. Rest of Europe
  • 5.3. Asia-Pacific
    • 5.3.1. China
    • 5.3.2. India
    • 5.3.3. Japan
    • 5.3.4. South Korea
    • 5.3.5. Rest of Asia-Pacific
  • 5.4. Rest of the World

6. Company Profiles

  • 6.1. Abbott Laboratories
  • 6.2. BIOTRONIK SE & Co KG
  • 6.3. Boston Scientific Corp.
  • 6.4. Cook Group Inc.
  • 6.5. Elixir Medical Corp.
  • 6.6. Hellman & Friedman LLC
  • 6.7. Integer Holdings Corp.
  • 6.8. iVascular, SLU
  • 6.9. LifeTech Scientific Corp.
  • 6.10. Meril Life Sciences Pvt. Ltd.
  • 6.11. MicroPort Scientific Corp.
  • 6.12. Stentys S.A.
  • 6.13. Vascular Concepts Ltd.
  • 6.14. Veryan Holdings Ltd.
  • 6.15. VESALIO, LLC